CYCCP

HEALTHCARE

Cyclacel Pharmaceuticals Inc 6 Convertible Preferred Stock

—PRE

Live · NASDAQ · May 8, Close

AI Insight

What's Moving CYCCP Today?

No stock-specific AI insight has been generated for CYCCP yet. Check back soon — insights are generated from recent news analysis.

Fundamentals

Market Cap$10M

P/E Ratio—

EPS$-2.05

Dividend Yield—

Dividend / Share—

ROE-2.8%

Profit Margin—

Debt / Equity—

Trading

Volume—

Avg Volume (10D)—

Shares Outstanding12.5M

CYCCP News

No news articles found for CYCCP yet.

Price Data

Open—

Previous Close—

Day High—

Day Low—

52 Week High$8.50

52 Week Low$3.36

Fundamentals

Market Cap$10M

P/E Ratio—

EPS$-2.05

Dividend Yield—

Dividend / Share—

ROE-2.8%

Profit Margin—

Debt / Equity—

Trading

Volume—

Avg Volume (10D)—

Shares Outstanding12.5M

About Cyclacel Pharmaceuticals Inc 6 Convertible Preferred Stock

Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops drugs for the treatment of cancer and other proliferative diseases. The company is headquartered in Berkeley Heights, New Jersey.

cyclacel.com

Listed February 6, 2026

HEALTHCAREBIOTECHNOLOGY

Company Details

Security TypeStock

ExchangeNASDAQ

CurrencyUSD

Round Lot—

SICBIOTECHNOLOGY

CIK—

Composite FIGI—

Share Class FIGI—